Brookshire Cypress Jersey Village Katy
1.9K Reviews    |    4.7 Star Rating    |    20+ years of experience    |    75k+ Patients Treated
Call

New-Onset Painless Jaundice Patient Journey in Katy, TX

How do clinicians urgently evaluate new painless jaundice, determine whether bilirubin is conjugated, localize bile-duct obstruction, distinguish stones and strictures from pancreatic or biliary cancer, and prevent cholangitis or liver dysfunction?

Martha’s path from painless jaundice, itching, fatigue, dark urine, and fluctuating cholestatic liver tests to PSC with a clinically significant dominant stricture, targeted care, and documented follow-up

Medically reviewed by: Dr. Bharat Pothuri, MD, FACG Specialty: Gastroenterology & Hepatology Last updated: 2026-08-18

GastroDoxs GutGuardians™

Your guardians. GastroDoxs GutGuardians™ is our team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.

Martha’s Story: Primary sclerosing cholangitis with a dominant bile-duct stricture

A 48-year-old school-district data analyst with ulcerative colitis looking for an explanation for painless jaundice, itching, fatigue, dark urine, and fluctuating cholestatic liver tests

Martha was a school-district data analyst with ulcerative colitis whose first explanation was a routine ulcerative colitis flare.

The decision changed when dark urine and cholestatic tests appeared without increased bowel symptoms. The combination of painless jaundice, itching, fatigue, dark urine, and fluctuating cholestatic liver tests required a more specific evaluation.

IBD history, MRCP beading, and a new dominant stricture supported PSC. ERCP evaluated and treated the narrowing while tissue sampling addressed cholangiocarcinoma risk.

The final plan used endoscopic therapy of the significant stricture when indicated, infection precautions, hepatology follow-up, IBD and cancer surveillance, and transplant assessment if disease progressed. Follow-up measured safety, symptom resolution, objective recovery, and the risk of recurrence.

The stricture needed treatment, but it also needed tissue evaluation because PSC changes cancer risk.

The First Signs: How Martha’s Symptoms Began

Martha first noticed painless jaundice and assumed a routine ulcerative colitis flare.

Additional symptoms developed: painless jaundice, itching, fatigue, dark urine, and fluctuating cholestatic liver tests.

The pattern became harder to dismiss when dark urine and cholestatic tests appeared without increased bowel symptoms.

That change led to testing selected for PSC with a clinically significant dominant stricture rather than another round of symptom-only treatment.

When Martha Understood What Had Changed

The turning point was replacing the assumption of a routine ulcerative colitis flare with evidence supporting PSC with a clinically significant dominant stricture.

At first, Martha tried to fit the symptoms into a familiar explanation.

The pattern no longer fit when dark urine and cholestatic tests appeared without increased bowel symptoms.

IBD history, MRCP beading, and a new dominant stricture supported PSC. ERCP evaluated and treated the narrowing while tissue sampling addressed cholangiocarcinoma risk.

The team explained why endoscopic therapy of the significant stricture when indicated, infection precautions, hepatology follow-up, IBD and cancer surveillance, and transplant assessment if disease progressed addressed the supported mechanism and what findings would require escalation.

That explanation turned several disconnected tests and recommendations into one coherent care path.

Uncertainty Became a Defined Question

Testing focused on confirming or excluding PSC with a clinically significant dominant stricture.

Urgency Was Matched to Risk

The care setting reflected bleeding, obstruction, infection, ischemia, perforation, and clinical stability.

Follow-Up Had an Endpoint

Symptoms, laboratory recovery, imaging, endoscopy, pathology, or postoperative milestones were used as appropriate.

Why Martha Needed More Than Symptom-Only Treatment

The record required one interpretation that connected the symptom pattern, diagnostic evidence, immediate risks, treatment mechanism, and follow-up endpoint.

The Initial Explanation Was Incomplete

The assumption of a routine ulcerative colitis flare no longer accounted for the full pattern.

Objective Evidence Changed the Differential

The team considered pancreatic, ampullary, gallbladder, and bile-duct cancer; choledocholithiasis; benign postoperative stricture; PSC; drug-induced cholestasis; viral or autoimmune hepatitis; hemolysis; and inherited bilirubin disorders.

Treatment Needed a Supported Target

The plan focused on PSC with a clinically significant dominant stricture rather than the symptom label alone.

Recovery Needed Measurement

The team defined symptom, laboratory, imaging, endoscopic, pathology, or postoperative endpoints appropriate to the case.

A Symptom Pattern Needs a Cause, a Safety Assessment, and a Follow-Up Endpoint

GastroDoxs can organize expedited stable jaundice evaluation and coordinate imaging, EUS, ERCP, tissue diagnosis, and specialist care. Fever, confusion, low blood pressure, or rapid decline requires emergency treatment.

How Martha’s Symptoms Led to Cause-Directed Care

The sequence moved from a nonspecific complaint to risk assessment, targeted testing, a supported diagnosis, treatment matched to the mechanism, and documented follow-up.

Testing Defines the Problem

IBD history, MRCP beading, and a new dominant stricture supported PSC. ERCP evaluated and treated the narrowing while tissue sampling addressed cholangiocarcinoma risk.

Review New-Onset Painless Jaundice →

The Mechanism Directs Treatment

The supported pattern was PSC with a clinically significant dominant stricture, so the plan used endoscopic therapy of the significant stricture when indicated, infection precautions, hepatology follow-up, IBD and cancer surveillance, and transplant assessment if disease progressed.

Review the treatment guide →

Follow-Up Measures Recovery

Jaundice improved after duct therapy, and Martha entered coordinated PSC, IBD, and malignancy surveillance.

Schedule stable review →

Decisions That Shaped Martha’s Evaluation

The first decisions are whether new painless jaundice includes an urgent warning sign, whether a common reversible trigger is present, and which examination or test can distinguish competing causes without unnecessary restriction or treatment.

Establish Timing and Severity

Record the first yellow discoloration, dark urine, pale stool, itching, fever, chills, pain, appetite, weight change, medications, supplements, travel, surgery, endoscopy, cancer risk, and prior liver tests.

Screen for Urgent Disease

Jaundice with fever, chills, confusion, low blood pressure, severe weakness, vomiting, abdominal pain, bleeding, or rapidly worsening illness requires emergency assessment for cholangitis, sepsis, acute liver failure, or another complication.

Examine the Relevant Systems

Assess sclera, skin, hydration, mental status, vital signs, scratch marks, abdominal tenderness, palpable gallbladder or mass, liver size, ascites, bruising, and signs of chronic liver disease.

Select Tests That Change Care

Urgent testing includes fractionated bilirubin, liver enzymes, CBC, INR, renal function, and ultrasound; CT pancreas protocol, MRI/MRCP, EUS, ERCP, hepatitis or autoimmune testing, and tissue acquisition are chosen from the obstruction level and clinical stability.

Define a Measurable Endpoint

Follow bilirubin and liver-test recovery, duct decompression, pathology and staging when relevant, symptom improvement, nutrition, procedural complications, and the definitive surgery, oncology, or surveillance plan.

Jaundice with fever, shaking chills, confusion, fainting, low blood pressure, severe weakness, persistent vomiting, new abdominal pain, bleeding, or rapidly worsening illness requires emergency care.

How Clinicians Interpreted Martha’s PSC-Associated Dominant Biliary Stricture

Clinicians interpret new painless jaundice through the symptom timeline, associated findings, medication and surgery history, nutrition, physical examination, response to prior treatment, and objective testing. Fever, chills, confusion, low blood pressure, worsening pain, vomiting, or rapid decline can indicate infected obstruction and sepsis. Even stable painless jaundice needs expedited—not watchful—evaluation.

A Symptom Is Not a Final Diagnosis

Important causes include pancreatic or ampullary cancer, cholangiocarcinoma, choledocholithiasis, benign postoperative stricture, primary sclerosing cholangitis, drug-induced cholestasis, viral or autoimmune hepatitis, and hemolysis.

Context Changes the Differential

Painless progressive jaundice with weight loss raises malignancy concern; fever suggests infected obstruction; recent surgery suggests stricture; a new medicine may cause cholestatic injury; hepatocellular and hemolytic patterns require different tests.

Testing Should Answer a Question

Urgent testing includes fractionated bilirubin, liver enzymes, CBC, INR, renal function, and ultrasound; CT pancreas protocol, MRI/MRCP, EUS, ERCP, hepatitis or autoimmune testing, and tissue acquisition are chosen from the obstruction level and clinical stability.

Failure to Improve Reopens the Case

Fever, chills, confusion, low blood pressure, worsening pain, vomiting, or rapid decline can indicate infected obstruction and sepsis. Even stable painless jaundice needs expedited—not watchful—evaluation.

PSC-Associated Dominant Biliary Stricture

IBD history, MRCP beading, and a new dominant stricture supported PSC. ERCP evaluated and treated the narrowing while tissue sampling addressed cholangiocarcinoma risk.

What Happened During Martha’s Stable GI Review

A stable visit for new painless jaundice reviews onset, pattern, associated GI and systemic symptoms, medicines, diet, prior operations, completed tests, self-treatment, nutrition, and the warning signs that determine whether office care remains appropriate.

Build a Precise Timeline

Record the first yellow discoloration, dark urine, pale stool, itching, fever, chills, pain, appetite, weight change, medications, supplements, travel, surgery, endoscopy, cancer risk, and prior liver tests.

Review Exposures and Treatments

Review antibiotics, anabolic agents, supplements, chemotherapy, alcohol, viral risks, travel, gallstones, pancreatitis, biliary surgery, cholecystectomy, transplant, IBD, PSC, and family cancer history.

Perform a Focused Examination

Assess sclera, skin, hydration, mental status, vital signs, scratch marks, abdominal tenderness, palpable gallbladder or mass, liver size, ascites, bruising, and signs of chronic liver disease.

Reconcile Existing Results

The team reviews original reports before adding urgent testing includes fractionated bilirubin, liver enzymes, cbc, inr, renal function, and ultrasound; ct pancreas protocol, mri/mrcp, eus, ercp, hepatitis or autoimmune testing, and tissue acquisition are chosen from the obstruction level and clinical stability.

Agree on Follow-Up

Follow bilirubin and liver-test recovery, duct decompression, pathology and staging when relevant, symptom improvement, nutrition, procedural complications, and the definitive surgery, oncology, or surveillance plan.

From PSC-Associated Dominant Biliary Stricture to a Defined Care Plan

Treatment for new painless jaundice targets the supported mechanism, protects nutrition and function, avoids unnecessary long-term restriction, and includes a defined reassessment point.

Correct the Supported Cause

Treatment may require urgent antibiotics and biliary drainage for cholangitis, endoscopic stone removal or stenting, surgery or oncology for malignancy, repair or dilation of a benign stricture, or withdrawal and monitoring of a culprit medicine.

Remove Aggravating Factors

Do not delay imaging while trying supplements, stop essential medicines without prescriber review, or assume a painless stone is harmless; avoid invasive procedures before coagulation, infection, and anatomy are assessed.

Protect Nutrition and Function

Address poor intake, weight loss, fat malabsorption, hydration, and fat-soluble vitamin risk in prolonged cholestasis, with nutrition support coordinated around procedures and the underlying disease.

Use Medicines Selectively

Antibiotics, antipruritic treatment, vitamin replacement, medication withdrawal, and disease-specific drugs depend on infection, cholestasis duration, liver function, obstruction, and the supported cause.

Escalate Persistent or Atypical Findings

Fever, chills, confusion, low blood pressure, worsening pain, vomiting, or rapid decline can indicate infected obstruction and sepsis. Even stable painless jaundice needs expedited—not watchful—evaluation.

How the Pathway Applied to Martha

For this composite, the plan used endoscopic therapy of the significant stricture when indicated, infection precautions, hepatology follow-up, IBD and cancer surveillance, and transplant assessment if disease progressed. The result was measured through this outcome: Jaundice improved after duct therapy, and Martha entered coordinated PSC, IBD, and malignancy surveillance.

Why Katy, TX Patients Benefit From Coordinated Records and Follow-Up

The Katy, TX plan linked the original acute or diagnostic setting with gastroenterology, radiology, pathology, surgery, primary care, and other services needed for PSC with a clinically significant dominant stricture.

One Diagnostic Record

The Katy, TX review reconciled imaging, endoscopy, pathology, laboratory trends, and treatment response.

Urgency Remained Explicit

The Katy, TX office handled stable review; active emergency warning signs returned to hospital-level care.

Specialists Had Defined Questions

Radiology, pathology, surgery, pelvic-floor, vascular, infectious-disease, or IBD input was requested only when it could change the plan.

Follow-Up Used Measurable Endpoints

The Katy, TX baseline allowed symptoms, blood counts, imaging, mucosal findings, or postoperative milestones to be compared over time.

GastroDoxs Painless Jaundice Expedited Jaundice Evaluation for Katy, TX

GastroDoxs can organize expedited stable jaundice evaluation and coordinate imaging, EUS, ERCP, tissue diagnosis, and specialist care. Fever, confusion, low blood pressure, or rapid decline requires emergency treatment.

Address

Memorial Hermann Katy - Medical Plaza 1, 23920 Katy Freeway, Suite 510, Katy, TX 77494

Office Hours

Monday through Friday, 7:00 AM to 7:00 PM

Areas Served

Katy, Cinco Ranch, Grand Lakes, Fulshear, Mason Road, and west Houston

Main Access Routes

Katy Freeway, Grand Parkway, Mason Road, and Katy Fort Bend Road

Planning Painless Jaundice Evaluation and Follow-Up

Coverage can differ for urgent laboratory testing, ultrasound, CT, MRI/MRCP, EUS, ERCP, anesthesia, stenting, biopsy and pathology, surgery, oncology, and hospitalization.

Confirm the Care Setting

Ask whether the planned service belongs in an office, endoscopy center, radiology department, hospital, infusion site, or surgical facility.

Verify Diagnostic Coverage

Imaging, endoscopy, pathology, capsule, functional testing, or specialist review may have separate authorization and cost-sharing rules.

Send Existing Records First

Prior images, pathology, operative notes, and laboratory trends can prevent unnecessary repetition and clarify the correct next service.

Do Not Delay Emergency Care

Coverage questions should never postpone evaluation of severe pain, major bleeding, persistent vomiting, sepsis signs, or bowel obstruction.

Why Martha Chose the Final Care Strategy

The selected plan matched diagnostic certainty, immediate risk, anatomy, the supported mechanism, prior response, and the least invasive option likely to be safe and effective.

The Pattern Was Supported

IBD history, MRCP beading, and a new dominant stricture supported PSC. ERCP evaluated and treated the narrowing while tissue sampling addressed cholangiocarcinoma risk.

The Risks Were Defined

The team considered pancreatic, ampullary, gallbladder, and bile-duct cancer; choledocholithiasis; benign postoperative stricture; PSC; drug-induced cholestasis; viral or autoimmune hepatitis; hemolysis; and inherited bilirubin disorders.

Treatment Matched the Cause

The plan used endoscopic therapy of the significant stricture when indicated, infection precautions, hepatology follow-up, IBD and cancer surveillance, and transplant assessment if disease progressed.

Escalation Criteria Were Explicit

New or worsening warning signs, failure to improve, objective recurrence, or a new structural concern triggered reassessment.

Obstructive and Nonobstructive Painless Jaundice Pathways

Bilirubin fraction, liver-enzyme pattern, ultrasound, cross-sectional imaging, duct anatomy, systemic signs, medication exposure, and tissue diagnosis distinguish the major pathways.

Malignant Obstruction Pathway

Use pancreas or liver-protocol imaging, EUS or ERCP, tissue, and staging.

Best for: Progressive painless jaundice, weight loss, double-duct or mass finding

Limitations: A negative early study may not settle the cause

Takeaway: Expedite diagnosis and drainage planning

Stone or Benign Stricture Pathway

Define duct anatomy and use therapeutic ERCP when appropriate.

Best for: Stone, postoperative narrowing, fluctuating jaundice, or duct dilation

Limitations: Infection can develop quickly

Takeaway: Drain infected obstruction urgently

Hepatocellular Cholestasis Pathway

Review medicines, viral, autoimmune, ischemic, and metabolic causes.

Best for: No dominant extrahepatic blockage and liver-predominant injury

Limitations: Mixed patterns are common

Takeaway: Match tests to the biochemical pattern

Hemolysis or Nonhepatic Mimic Pathway

Use blood count, hemolysis testing, and examination.

Best for: Predominantly unconjugated bilirubin without dark urine

Limitations: A second liver problem can coexist

Takeaway: Fractionate bilirubin first

When Symptoms Associated With New-Onset Painless Jaundice Need Prompt or Emergency Care

These findings can indicate infected biliary obstruction, sepsis, acute liver failure, significant bleeding, progressive malignancy, or another time-sensitive hepatobiliary condition.

Fever or shaking chills with jaundice
Confusion, unusual drowsiness, or altered behavior
Fainting, low blood pressure, rapid pulse, or severe weakness
New or worsening right-upper abdominal pain
Persistent vomiting or inability to keep fluids down
Vomiting blood, black stool, or significant bleeding
Rapidly deepening jaundice or very dark urine with minimal output
Unintended weight loss, early satiety, or a new abdominal mass
Marked bruising, abdominal swelling, or new swelling of the legs
Severe generalized itching with skin breakdown or inability to sleep or eat

Martha’s Life After a Cause-Directed Plan

How care for PSC with a clinically significant dominant stricture changed symptoms, safety, and follow-up

Jaundice improved after duct therapy, and Martha entered coordinated PSC, IBD, and malignancy surveillance.

The result followed endoscopic therapy of the significant stricture when indicated, infection precautions, hepatology follow-up, IBD and cancer surveillance, and transplant assessment if disease progressed.

Follow-up did not rely on symptom improvement alone; relevant blood counts, nutrition, inflammatory markers, imaging, endoscopy, pathology, bowel function, or postoperative findings were considered.

Martha understood which recurrence patterns could use planned review and which warning signs required emergency assessment.

The record preserved the diagnostic reasoning so future clinicians could distinguish a known recurrence from a new and unrelated GI problem.

The stricture needed treatment, but it also needed tissue evaluation because PSC changes cancer risk.
Educational Disclaimer

This educational composite illustrates primary sclerosing cholangitis with a dominant bile-duct stricture. It does not represent a specific patient, establish a diagnosis, or promise a result. Jaundice with fever, shaking chills, confusion, fainting, low blood pressure, severe weakness, persistent vomiting, new abdominal pain, bleeding, or rapidly worsening illness requires emergency care.

New-Onset Painless Jaundice FAQs in Katy, TX

Answers about causes, diagnostic testing, treatment choices, complications, follow-up, office access, and urgent warning signs

In Katy, TX, Martha’s evaluation supported PSC with a clinically significant dominant stricture. The conclusion used liver tests, ultrasound, MRI/MRCP, IBD record review, ERCP with brushings or biopsy for a significant stricture, and cancer-surveillance assessment and the full symptom timeline rather than the symptom label alone.

For a patient in Katy, TX, new yellowing of the eyes or skin without pain is still an alarm sign; bilirubin pattern, urine and stool color, liver tests, and imaging define the cause.

For a Katy, TX patient, causes include pancreatic or bile-duct tumors, an ampullary lesion, stones, postoperative stricture, PSC, drug-induced cholestasis, hepatitis, and hemolysis.

The Katy, TX workup used liver tests, ultrasound, MRI/MRCP, IBD record review, ERCP with brushings or biopsy for a significant stricture, and cancer-surveillance assessment. Testing was selected to distinguish PSC with a clinically significant dominant stricture from plausible alternatives and to identify findings that would change treatment.

The Katy, TX plan used endoscopic therapy of the significant stricture when indicated, infection precautions, hepatology follow-up, IBD and cancer surveillance, and transplant assessment if disease progressed. Follow-up measured this outcome: Jaundice improved after duct therapy, and Martha entered coordinated PSC, IBD, and malignancy surveillance.

In Katy, TX, malignant obstruction, a duct stone, benign stricture, drug injury, viral or autoimmune hepatitis, and hemolysis can initially look similar.

A Katy, TX patient should track the onset of yellowing, urine and stool color, itching, fever, pain, weight, appetite, medicines, supplements, surgery, ERCP, alcohol, travel, and prior liver tests.

A Katy, TX patient should arrange review when yellowing is new, progressive, unexplained, or accompanied by dark urine, pale stool, itching, weight loss, abnormal liver tests, or duct dilation—even without pain.

GastroDoxs evaluates stable new painless jaundice for Katy, TX patients at Memorial Hermann Katy - Medical Plaza 1, 23920 Katy Freeway, Suite 510, Katy, TX 77494. Office hours are Monday through Friday, 7:00 AM to 7:00 PM.

A Katy, TX patient should seek urgent care for fever, shaking chills, confusion, fainting, low blood pressure, severe weakness, persistent vomiting, new abdominal pain, bleeding, or rapid worsening. These symptoms should not wait for routine office hours.

GastroDoxs GutHero Quest™

  1. 1

    Define the Pattern

    Record the first yellow discoloration, dark urine, pale stool, itching, fever, chills, pain, appetite, weight change, medications, supplements, travel, surgery, endoscopy, cancer risk, and prior liver tests.

  2. 2

    Check Safety First

    Jaundice with fever, chills, confusion, low blood pressure, severe weakness, vomiting, abdominal pain, bleeding, or rapidly worsening illness requires emergency assessment for cholangitis, sepsis, acute liver failure, or another complication.

  3. 3

    Identify the Leading Mechanism

    Important causes include pancreatic or ampullary cancer, cholangiocarcinoma, choledocholithiasis, benign postoperative stricture, primary sclerosing cholangitis, drug-induced cholestasis, viral or autoimmune hepatitis, and hemolysis.

  4. 4

    Confirm What Changes Care

    Urgent testing includes fractionated bilirubin, liver enzymes, CBC, INR, renal function, and ultrasound; CT pancreas protocol, MRI/MRCP, EUS, ERCP, hepatitis or autoimmune testing, and tissue acquisition are chosen from the obstruction level and clinical stability.

  5. 5

    Treat the Supported Cause

    Treatment may require urgent antibiotics and biliary drainage for cholangitis, endoscopic stone removal or stenting, surgery or oncology for malignancy, repair or dilation of a benign stricture, or withdrawal and monitoring of a culprit medicine.

  6. 6

    Measure Recovery and Reassess

    Follow bilirubin and liver-test recovery, duct decompression, pathology and staging when relevant, symptom improvement, nutrition, procedural complications, and the definitive surgery, oncology, or surveillance plan.

Need a Painless Jaundice Review in Katy, TX?

GastroDoxs can organize expedited stable jaundice evaluation and coordinate imaging, EUS, ERCP, tissue diagnosis, and specialist care. Fever, confusion, low blood pressure, or rapid decline requires emergency treatment. Stable review is available in Katy, TX.